CADL icon

Candel Therapeutics
CADL

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$18.33
192% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Stephens & Co
Stephens & Co
Sudan Loganathan
50% 1-yr CADL win rate
8 Dec ‘25 1 month ago
Citigroup
Citigroup
Yigal Nochomovitz
50% 1-yr CADL win rate
14 Nov ‘25 2 months ago
LifeSci Capital
LifeSci Capital
100% 1-yr CADL win rate
21 Oct ‘25 2 months ago